Table 1 Summary of patient characteristics.

From: Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer

Characteristic

 

Number of patients

49

Age [years]

 Median

66

 Range

24–89

Gender

 Male

38

 Female

11

UICC stage

 IV

49

Survival time [months]

 Median

14

 Range

0–80

HER2 IHC score

 0+

0

 1+

0

 2+

9

 3+

40

HER2 CISH

 Amplified

47

 Non-amplified

0

 n.a.

2

  1. Samples with insufficient data to make a conclusion were set to ‘n.a.’.
Back to article page